Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00267020
Status:
COMPLETED
Last Update Posted:
2020-08-31
First Post:
2005-12-16
Brief Title:
Phase 2 Study of Gemcitabine or Gemcitabine Enzastaurin in Participants With Advanced or Metastatic Pancreatic Cancer
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-12
Start Date Type:
None
Primary Completion Date:
2008-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-05
Completion Date Type:
ACTUAL
First Submit Date:
2005-12-16
First Submit QC Date:
December 16 2005
Study First Post Date:
2005-12-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2020-08-31
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2009-06-10
Disp First Submit QC Date:
October 5 2009
Disp First Post Date:
2009-10-07
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2020-08-17
Last Update Post Date:
2020-08-31
Last Update Post Date Type:
ACTUAL